Come up with a name for your new list and we'll add to it:
Akebia Therapeutics raised a round of funding on , . Investors include
Queen City Angels.
Akebia Therapeutics is focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Akebia's lead product candidate, vadadustat, is an inv…